SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 56.98+1.1%Nov 5 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: JamesK1/21/2023 2:48:45 PM
1 Recommendation

Recommended By
Lance Bredvold

   of 52153
 
FGEN - this company may be back from the dead. The open label trial in non ambulatory DMD shows a completion date of Jan 31. Maybe some news coming with that. Followed after that with the controlled trial in non ambulatory DMD in the first half. Doubt there's much from DMD baked into the stock price.

The MDS trial with Roxa reads out first half. Not sure it's a big indication but they are still owed a bunch of big milestones from AZN that this might help hit.

Then IPF mid year.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News